Literature DB >> 8773091

Do we need anti snake venom (ASV) for management of elapid ophitoxaemia.

B S Bomb1, S Roy, D C Kumawat, M Bharjatya.   

Abstract

Twelve patients of elapid ophitoxaemia presented with neuromuscular paralytic features were given anticholinesterase (Neostigmine) in recommended dosage. In four of these patients, despite neuromuscular paralysis, no ASV was used. All these four patients survived. In eight patients, ASV was used; in three of whom it used in doses less than 50 units, yet patients survived. Of the remaining five, despite use of ASV in higher doses (more than 50 units), two succumbed to death. Eight patients required ventilatory support. Hence, in absence of any definite role of ASV in management of elapid ophitoxaemia (snake bite), use of anticholinesterase drugs alone, with good supportive care and prevention of likely complications, can result in satisfactory outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773091

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Is the patient brain-dead?

Authors:  R Agarwal; N Singh; D Gupta
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

2.  Retrospective analysis of snake victims in Northern India admitted in a tertiary level institute.

Authors:  Syed Moied Ahmed; Abu Nadeem; Mohd Sabihul Islam; Shiwani Agarwal; Lalit Singh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

3.  Judicious use of antisnake venom in the present period of scarcity.

Authors:  Srikant R Gadwalkar; N Sunil Kumar; D P Kushal; G Shyamala; M Z Mohammad; Huggi Vishwanatha
Journal:  Indian J Crit Care Med       Date:  2014-11

Review 4.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.